HS
Hughes Steven George
Chief Medical Officer
OFFICERM
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Hughes Steven George, Chief Medical Officer. Officer active across 2 companies, notably Avidity Biosciences, Inc.. Cumulatively, 14 disclosures have been logged. Split: 0 buy · 5 sells. Total volume traded: €672k. Activity tracked since 6 January 2025. The latest transaction was disclosed on 20 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hughes Steven George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
30,000 股0Common StockSEC:0001193125-26-170963:0
115,857 股Common StockSEC:0001193125-26-082277:0
2,017 股@ US$72.4513.8% 占其流量Common StockSEC:0001599901-26-000026:0
2,373 股@ US$72.2316.3% 占其流量Common StockSEC:0001599901-26-000009:0
2,209 股@ US$10.160.0085% mcap50.0% 占其流量Common StockSEC:0001599901-25-000200:0
2,208 股@ US$10.164.1% 占其流量Common StockSEC:0001599901-25-000190:0
2,208 股@ US$40.5816.5% 占其流量Common StockSEC:0001599901-25-000190:1
1,542 股@ US$6.571.4% 占其流量Common StockSEC:0001599901-25-000186:0
2,208 股@ US$10.163.1% 占其流量Common StockSEC:0001599901-25-000166:0
1,542 股@ US$6.571.4% 占其流量Common StockSEC:0001599901-25-000159:0
11,283 股@ US$15.9626.0% 占其流量Common StockSEC:0001599901-25-000150:0
9,578 股@ US$31.059859.4% 占其流量Common StockSEC:0001599901-25-000075:0
1,915 股@ US$28.595511.5% 占其流量Common StockSEC:0001599901-25-000031:0
25,000 股0Common StockSEC:0001599901-25-000019:0
About Hughes Steven George
Steven George Hughes is the Chief Medical Officer at Avidity Biosciences, Inc. He oversees the company's medical and clinical initiatives, ensuring that the developed products meet safety and efficacy standards. His role is crucial for innovation and treatment development in the biotechnology field.